Educational, research-use-only content. This article summarizes published scientific literature for informational purposes only and is not medical advice. The compounds discussed are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.
Epitalon is frequently discussed in the context of aging and telomere biology. This article separates what the published, PubMed-indexed research has actually examined from the broader claims that circulate online.
What is Epitalon?
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It was designed by a St. Petersburg research group as a short “peptide bioregulator” modeled on a pineal-gland peptide preparation (Khavinson, 2002). In the laboratory it is studied as a tool for investigating gene-expression, circadian, and aging-related processes.
Telomerase and telomere research
One frequently cited in-vitro study reported that adding Epithalon to cultured telomerase-negative human fetal fibroblasts induced expression of the telomerase catalytic subunit, telomerase enzymatic activity, and telomere elongation (Khavinson et al., 2003). This is cell-culture research into a mechanism — not evidence of an outcome in a living human.
Aging and lifespan models
A review of the bioregulator program summarizes animal findings, including reported increases in lifespan in mice and fruit flies and restoration of circadian melatonin and cortisol rhythms in aged rhesus monkeys (Khavinson, 2002). These are animal-model observations.
Tumor-model research
In a study of female C3H/He mice given small doses over several months, Epitalon was associated with fewer malignant tumors and an absence of metastases compared with controls, with no toxicity reported at the doses used (Kossoy et al., 2006). As with the above, this is a preclinical animal model.
The limits of the current evidence
- Animal and cell models dominate; effects in humans are not established.
- Concentration in one research group. A large share of Epitalon literature comes from the same institute, and independent replication remains limited.
- Not an approved drug. Epitalon has not been evaluated by the U.S. Food and Drug Administration and is not approved for human use.
References
According to PubMed:
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003. doi:10.1023/a:1025493705728
- Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002. PMID:12374906
- Kossoy G, Anisimov VN, Ben-Hur H, et al. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo. 2006. PMID:16634527
